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Abstract:  Depression  and  coronary  artery  disease  (CAD)  are  both  extremely  prevalent 
diseases.  In  addition,  compromised  quality  of  life  and  life  expectancy  are  characteristics 
of both situations. There are several conditions that aggravate depression and facilitate the 
development of CAD, as well as provoke a worse prognosis in patients with already established 
CAD: inferior adherence to medical orientations (medications and life style modifications), 
greater platelet activation and aggregation, endothelial dysfunction, and impaired autonomic 
dysfunction (lowered heart rate variability). Recent literature has shown that depression alone 
is becoming an independent risk factor for cardiac events both in primary and secondary 
prevention. As the diagnosis of depression in patients with heart disease is difficult, due 
to similarities of symptoms, the health professional should perform a careful evaluation to 
differentiate the clinical signs of depression from those related with general heart diseases. 
After a myocardial infarction, depression is an independent risk factor for mortality. Successful 
therapy of depression has been shown to improve patients’ quality of life and cardiovascular 
outcome. However, multicentric clinical trials are needed to support this inference. A practical 
liaison between qualified professionals is necessary for the better management of depressed 
patients with excess risk in developing CAD. Accordingly, pathophysiological and clinical 
implications between depression and CAD are discussed in this article.
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Introduction
It is well known that depression is highly prevalent among patients with coronary artery 
disease (CAD) at approximately three times greater than in the general population.1 
In addition, depression behaves as a risk factor for the development of CAD, and 
worsens outcome when present in patients with established CAD.2,3 The prevalence of 
major depression in patients with CAD is approximately 20%,4,5 making depression a 
condition affecting millions of patients with CAD annually. Although the mechanisms 
underlying this connection remain unclear, it has been suggested that depression is 
associated with both physiological and psychosocial changes that are deleterious to 
the cardiovascular system.6
Published studies suggest that depression is a particularly strong psychosocial 
predictor of CAD onset and progression. As the link between depression and CAD has 
become increasingly predictable and established between specialists, pharmacologic 
and nonpharmacologic interventions on depression in patients with heart disease have 
come into practice. Depression has a harmful effect on the cardiovascular system. 
Supposedly, treatment of depression should lessen its negative prognostic outcome.7 Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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A very vital aspect of continued therapeutic advances in 
this arena have shown a persuasive link between   successful 
management of depression in patients with CAD and a 
  reduction in cardiovascular events. However, the investiga-
tions addressing this hypothesis have demonstrated a variety 
of conclusions.8,9
Outstandingly, besides depression, disorders of behavior 
such as irritability, anger, and hostility are also associated 
with the major clinical events of CAD.10
The purpose of this article is to review some of the most 
important pathophysiological and clinical aspects in the field 
of depression and CAD. In essence, the authors propose to 
discuss the cause–effect association between depression 
and CAD and the perplexity of detecting depression in a 
patient with CAD. In addition, other situations of emotional 
disorders are approached as to also evaluate their associations 
with CAD.
Current status of the mechanistic 
pathways between depression  
and CAD
Established coronary risk factors such as hypercholester-
olemia, hypertension, diabetes, obesity, and smoking are 
bound to accumulate in depressed patients.11 However, in 
1987, a meta-analysis of studies published between 1945 
and 1985, about psychosocial predictors of CAD concluded 
that depression is the main psychosocial risk factor for 
  cardiovascular disease.5
A number of reasonable biobehavioral mechanisms are 
suggested to underlie the relationship between depression 
and CAD: treatment adherence and lifestyle factors such 
as smoking, heavy alcohol use, and physical inactivity. 
  Depression foresees reduced adherence to prescribed 
regimens. No adherence to recommended lifestyle changes 
and medication regimes itself is associated with a poor 
outcome for CAD patients,12 suggesting that adherence may 
be a mechanism linking depression and CAD outcomes. 
Depression is also related with increased rates of smoking 
and may lower the success of smoking cessation programs in 
CAD patients.13 Depression also is associated with increased 
alcohol intake and physical inactivity.14
Other mechanisms linking depression and heart disease 
include autonomic imbalance, platelet-endothelial interac-
tion, neurohumoral activation, inflammation, and polymor-
phism in the serotonin gene transport.15
The mechanistic pathways relating depression and CAD 
are summarized in Figure 1.
Dysregulation of the autonomic nervous 
system
Autonomic imbalance, characterized by disproportion-
ate sympathetic activation and/or altered vagal activation, 
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Figure 1 Pathophysiologic mechanisms between depression, anger and hostility, and cardiovascular disease.10 
Abbreviations: ANS, autonomous nervous system; HPA, hypothalamus–pituitary–adrenal; LDL-C, low density lipoprotein cholesterol; HDL-C, high-density lipoprotein 
cholesterol; AP, arterial blood pressure; iL, interleukin; TNF, tumor necrosis factor.Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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are associated with higher incidence of morbidity and 
mortality.16
The relationship between depression and heart rate vari-
ability is explained by the effect of depression in the balance 
between the sympathetic and parasympathetic   systems, which, 
in turn, affects the cardiac pacemaker. Carney et al17 reported 
that patients with CAD and depression had significantly less 
heart rate variability than non-depressed cardiac patients. 
Absence of heart rate variability understands a sympathetic-
vagal disparity and is a risk factor for   ventricular arrhythmias 
and sudden cardiac death in patients with cardiovascular dis-
ease.18 This situation is aggravated among depressed patients 
that suffer a myocardial infarction, which suggests that low 
heart rate variability may facilitate the adverse outcome of 
depression on survival after a myocardial infarction.
Platelet activation and endothelial 
dysfunction
The association between depression and CAD may also 
be mediated by changes in platelet activation. Platelets 
play a central role in homeostasis and the development of 
  atherosclerosis, thrombosis, and acute coronary syndromes 
by means of its interaction with subendothelial components 
of affected vessels and with coagulation factors.
Enhanced platelet reactivity is common within depressed 
patients. Plasma levels of platelet factor IV and beta-
thromboglobulin, markers of platelet activation, are higher 
in depressed patients with ischemic heart disease than in 
nondepressed patients with ischemic heart disease and con-
trol patients.19
Interestingly, in a substudy of the Sertraline Anti-
  Depressant Heart Attack Randomized Trial, depressed 
myocardial infarction patients that were treated with sertraline, 
a selective serotonin reuptake inhibitor, presented substan-
tially less activation of platelets and endothelial cells.20
Endothelial dysfunction, denoted by altered flow-
mediated dilation of the brachial artery, can be also 
present in depressed patients that do not present traditional 
atherosclerotic risk factors.21
Hypothalamic–pituitary–adrenocortical 
(HPA) and sympathetic adrenal medullary 
(SAM) activation
High blood levels of cortisol induces endothelial injury 
which, in turn, mediates hypertension and atherosclerosis. 
Sympathoadrenal activation leads to catecholamine 
production and subsequent tachycardia, vasoconstriction, 
and platelet activation. A mechanism by which a worse 
clinical outcome can be installed in depressed patients is the 
excessive stimulation of the HPA and SAM systems.22
Inflammatory markers
There is some preliminary evidence suggesting that 
alterations in immune functioning and inflammation may be 
the link between depression and CAD, however, it is not clear 
that patients with CAD have a greater inflammation status if 
depression exists.23 Depressed patients have higher levels of 
C-reactive protein and inflammatory cytokines, which play 
important roles in atherogenesis.24 A recent investigation 
evaluated direct associations between levels of depression 
and C-reactive protein concentrations in patients that suffered 
a myocardial infarction.25
Since vagal tone inhibits the secretion of inflammatory 
cytokines, treatments that stimulate the vagus nerve such as 
exercise, biofeedback, and meditation may have favorable 
anti-inflammatory consequences.26
Genetic polymorphism in the serotonin 
transport promoter region gene
Serotonin transport promoter region gene (5-HTTLPR) exists 
in two forms, a long one and a less-effective short one that 
appears to predispose to depression. Patients with myocardial 
infarction that possessed one or both of their alleles of this 
short gene were more likely to become depressed and to have 
subsequent cardiac events.27
Depression: difficult to diagnose 
within patients with CAD
The diagnosis of depression in the presence of heart 
disease is hampered by the similarity of symptoms in 
both conditions such as lack of energy, lack of appetite, 
fatigue, insomnia, and difficulty concentrating.28 Screen-
ing assessment for depressive manifestations is useful to 
identify patients who may require further stratification 
and management.29 The opportunity to screen for and treat 
depression in cardiac patients should not be missed, as 
effective depression treatment may reduce morbidity and 
mortality. If positive screening results are established, 
evaluation by qualified professionals is preferred.
Medical literature has shown that up to 20% of patients 
with recent myocardial infarction meet the Diagnostic 
and Statistical Manual of Mental Disorders-IV30 criteria Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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for major depression and even more present depressive 
manifestations. Contemporary evidence has also noted 
elevated health care expenses, poor   quality of life, deprived 
adherence to therapy, and two times greater the   mortality 
rate within depressed patients who experience clinical 
  manifestations of CAD, such as myocardial   infarction. 
  However, the diagnosis, and subsequent treatment, of 
depression among CAD patients has been suboptimal 
despite this high prevalence. To attend this dilemma further, 
the American Heart Association (AHA) has recently pub-
lished a science advisory for clinicians, which recommends 
routine screening for depression in CAD patients.31 The 
American Psychiatric Association endorsed this advisory.
The Patient Health Questionnaire (PHQ-2)32 offers two 
queries that are suggested for identifying depressed patients. 
If the answer is “yes” to one or both of the questions, it is 
recommended that PHQ-933, which contains nine questions, 
should be made available. The PHQ-9 is a concise depres-
sion-screening tool. The   majority of the patients are capable 
of answering completely in at least five minutes, without 
assistance. It provides a conditional diagnosis of depression 
as well as the severity stratification, which is helpful for 
treatment selection and monitoring.
Follow-up during a succeeding appointment is counseled 
for patients with mild manifestations. In patients with 
elevated scores, a review with a qualified professional should 
be done. However, it is important to point out that depressive 
symptoms may be present due to the complexity of the medi-
cal condition.
The current AHA advisory is very much related to the 
rationale expanded by the MacArthur Initiative on Depression 
and Primary Care,34 which offers information for the recogni-
tion and management of depression in primary care settings for 
depression screening and care guidelines for cardiologists.35
Patients with high screening scores in the PHQ-9 
query (score of 10 or higher) should be referred for a more 
comprehensive clinical evaluation. During this evaluation, 
the presence of other mental disorders (eg, anxiety and 
irritability) should be investigated, which have also been 
shown to be associated with adverse outcomes in cardiac 
patients.36 PHQ-2, PHQ-9 and other details can be analyzed 
in the following link. http://circ.ahajournals.org/cgi/
reprint/118/17/1768.pdf
With the aim of facilitating diagnosis of depression in 
CAD patients, some authors proposed changes in   diagnostic 
criteria. Cavanaugh37 suggested additional criteria that 
would be more effective in this group of patients, such as 
hopelessness, loss of interest particularly for people, poor 
adherence to treatment, recurrent thoughts of death related 
to depressive symptoms, and recurrent thoughts of recovery 
from clinical condition below the expected.
in-hospital depression
Evaluating patients with acute myocardial infarction still 
in hospital, Lesperance et al38 found that sadness was the 
most specific symptom in patients previously depressed and 
was not a common complaint in patients with CAD without 
previous diagnosis of depression. Another interesting fact 
is that depressed patients complained less of lack of interest 
than sadness. In addition, fatigue was significantly more 
frequent in depressed (71%) than in non-depressed (23%) 
patients. Therefore, before attributing fatigue solely to 
heart disease, the cardiologist should evaluate the patient 
with attention to rule out the possibility of depression. 
On the other hand, symptoms like sleep disturbances and 
changes in appetite had little importance in   differentiating 
depressed from   nondepressed CAD patients. Problems with 
sleep and appetite are very   common in both conditions.
Other emotional disorders
Other very frequent symptoms present in patients with CAD 
are anger/hostility, which may confound the diagnosis of 
depression.39 Attention should be given to a patient with 
anger/hostility, making the diagnosis of either depression 
and/or CAD difficult. In the presence of an irritable mood, 
such as anger/hostility, it is very important that the   cardiologist 
actively investigate other symptoms of   depression. In a recent 
publication, Chida and Steptoe40 report, on a meta-analysis 
of prospective studies, a 20% increased risk of both incident 
CAD in initially healthy individuals and poor prognosis in 
CAD patients.
Sudden strong emotional stress can lead to transient and 
reversible left ventricular dysfunction, even in individuals 
without coronary disease, an effect that may be mediated by 
elevated plasma catecholamine levels.41 The chest pain and 
electrocardiographic findings simulate an acute myocardial 
infarction with ST segment elevation. Normal coronary 
arteries in the angiogram are characteristic of this condition, 
denoted cardiomyopathy by stress. Examples of emotional 
stress are generally related to a strong abhorring; sometimes 
for loss of a close relative. The emotional impact felt is of 
such magnitude that this frame was popularly known as 
“brokenhearted”. This condition is more common among 
women aged 40 to 50 years. The Japanese described this phe-
nomenon in the left ventricle as “tako tsubo”, coming from the 
fishing net used in regional fishing of octopus (Figure 2).Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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Conclusion
Numerous investigations strongly point out that depression is 
a significant and independent risk factor for CAD in both non-
CAD and CAD patients, with a relative risk of about 2.0. It is 
possible that depression is merely a psychosocial risk factor, 
such as others like anger, hostility, stress, and anxiety.
Difficulties in distinguishing depression from CAD 
symptoms may lead to misdiagnosis and inadequate 
management of these two conditions. Patients with heart 
disease must be evaluated in detail in order to differentiate 
depression from the symptoms related to heart disease in 
general. Many patients with cardiovascular disease will 
encounter mild depression that is not easy to distinguish 
from a normal grief response to the diagnosis of a signifi-
cant illness, while many others will experience moderate to 
severe depression.
Several reasonable biobehavioral mechanisms for which 
preliminary support exists, including treatment adherence, 
lifestyle factors, traditional risk factors including platelet 
reactivity, HPA and SAM axis imbalance, and inflammation. 
Recent publications suggest the role of a polymorphism in 
the promoter region of the gene 5-HTTLPR in predisposing 
depression.
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